Kolexia
Colombel Marc
Chirurgie urologique
Hôpital Edouard Herriot
Lyon, France
180 Activités
650 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Tumeurs de la vessie urinaire Carcinomes Non-Muscle Invasive Bladder Neoplasms Invasion tumorale Récidive tumorale locale Tumeurs du rein Néphrocarcinome Carcinome transitionnel

Industries

Ipsen
3 collaboration(s)
Dernière en 2021
Bouchara-Recordati
2 collaboration(s)
Dernière en 2021
Janssen
2 collaboration(s)
Dernière en 2023
Astellas
2 collaboration(s)
Dernière en 2022

Dernières activités

ELASTO-US: Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer Treatment Feasibility Study
Essai Clinique (EDAP TMS S.A.)   15 mars 2024
UCM301: Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer
Essai Clinique (ICON plc)   14 mars 2024
L’intelligence artificielle pour améliorer les performances de la cytologie dans le diagnostic du carcinome urothélial de la vessie résultats de l’étude prospective française multicentrique VISIOCYT1
117e congrès français d'urologie   01 novembre 2023
Zone-specific computer-aided diagnosis system aimed at characterizing ISUP ≥ 2 prostate cancers on multiparametric magnetic resonance images: evaluation in a cohort of patients on active surveillance.
World journal of urology   17 octobre 2023
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial.
European urology open science   12 septembre 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
World journal of urology   22 juillet 2023
Characterization of high-grade prostate cancer at multiparametric MRI using a radiomic-based computer-aided diagnosis system as standalone and second reader.
Diagnostic and interventional imaging   20 mai 2023
TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization.
Microbial cell (Graz, Austria)   19 avril 2023
Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study).
Insights into imaging   20 mars 2023
Prostatic arterial embolization versus holmium laser enucleation of the prostate: 1-year outcomes.
World journal of urology   01 décembre 2022